InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,486.61
(
0.16%
)
US TECH 100
19,320.80
(
0.55%
)
Dow Jones
39,188.30
(
0.15%
)
Brent Oil
85.14
(
0.79%
)
Bitcoin
62,186.00
(
2.26%
)
Post# of 252398
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119931
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 190041

Monday, 07/20/2015 11:11:24 AM

Monday, July 20, 2015 11:11:24 AM

Post# of 252398
BMY—CheckMate-025 Opdivo trial in second-line RCC stopped early for OS superiority vs Afinitor control arm:

http://finance.yahoo.com/news/checkmate-025-pivotal-phase-iii-120000343.html

Details (including the HR and p-value) will be presented at a medical conference.

This is Opdivo’s sixth or seventh trial stopped early for efficacy (I’ve lost count), but the first one stopped early for efficacy in OS specifically.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up